Screening of tobacco smoke condensate for nicotinic acetylcholine receptor ligands using cellular membrane affinity chromatography columns and missing peak chromatography.
about
Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of ADEffects of tobacco smoke constituents, anabasine and anatabine, on memory and attention in female rats.The development and characterization of protein-based stationary phases for studying drug-protein and protein-protein interactions.The preparation and development of cellular membrane affinity chromatography columns.Development and characterization of the α3β4α5 nicotinic receptor cellular membrane affinity chromatography column and its application for on line screening of plant extractsTobacco smoke exposure induces nicotine dependence in ratsInvestigation of molecular recognition in biological systems using cellular membrane affinity chromatography.Differential effects of non-nicotine tobacco constituent compounds on nicotine self-administration in ratsMolecular imprinting science and technology: a survey of the literature for the years 2004-2011.Comparison of analytical techniques for the identification of bioactive compounds from natural products.Nicotine-, tobacco particulate matter- and methamphetamine-produced locomotor sensitisation in rats.Behavioral changes after nicotine challenge are associated with α7 nicotinic acetylcholine receptor-stimulated glutamate release in the rat dorsal striatum.Target-directed screening of the bioactive compounds specifically binding to β₂-adrenoceptor in Semen brassicae by high-performance affinity chromatography.Confirming therapeutic target of protopine using immobilized β2 -adrenoceptor coupled with site-directed molecular docking and the target-drug interaction by frontal analysis and injection amount-dependent method.Repeated Administration of Cigarette Smoke Condensate Increases Glutamate Levels and Behavioral Sensitization.
P2860
Q28547449-544A2C3B-FE1D-4C25-8435-9F00F7B099CEQ35009475-4F255A0A-2BB7-4B86-BA64-2E0BE9F86789Q35243889-54DCB2B4-24CB-4F57-9ECD-C2BDF57A7F12Q36160925-381893D1-BDE5-4B9F-90BC-6AF6A8C498DAQ36565589-8DBAE683-F773-49F7-B021-C2F2134E5276Q36650308-F1BCF833-BA02-4561-AC9C-5512A8779C02Q37183605-BE5CED36-0983-4301-858D-140ABBD051A8Q37725084-6BC5A3DD-8D8E-4CD2-A4CB-F838F4089DABQ38202089-87A7456F-A2F6-4B51-AD7E-A77C3935FE26Q38883401-343CFBB7-4CAB-40A2-89B8-65FDE6A93FDEQ46143485-5C056E2A-339F-409A-8C0D-E9564F12808EQ47096343-C0AF964F-C11D-4C0F-BEE5-00551B473825Q47412006-28313646-8BCC-465E-968C-1E4DCF3A6FC0Q48309880-45B5428B-4242-41E8-A881-A3424D91EF9AQ53418793-56F142AB-5262-4886-8811-F543D9122716
P2860
Screening of tobacco smoke condensate for nicotinic acetylcholine receptor ligands using cellular membrane affinity chromatography columns and missing peak chromatography.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Screening of tobacco smoke con ...... d missing peak chromatography.
@en
Screening of tobacco smoke con ...... d missing peak chromatography.
@nl
type
label
Screening of tobacco smoke con ...... d missing peak chromatography.
@en
Screening of tobacco smoke con ...... d missing peak chromatography.
@nl
prefLabel
Screening of tobacco smoke con ...... d missing peak chromatography.
@en
Screening of tobacco smoke con ...... d missing peak chromatography.
@nl
P2093
P2860
P1476
Screening of tobacco smoke con ...... nd missing peak chromatography
@en
P2093
Irving W Wainer
Jun Haginaka
Ruin Moaddel
P2860
P304
P356
10.1016/J.JPBA.2007.11.024
P577
2007-11-26T00:00:00Z